−2 ) adults. The vasodilator response to BQ-123 was significantly lower (ß25%) and the FBF responses to acetylcholine were ß35% higher after exercise training. Before the exercise intervention, the co-infusion of acetylcholine plus BQ-123 resulted in a greater vasodilator response than acetylcholine alone; however, after the exercise intervention the FBF response to acetylcholine was not significantly increased by ET A receptor blockade. These results demonstrate that regular aerobic exercise reduces ET-1-mediated vasoconstrictor tone in previously sedentary overweight and obese adults. Moreover, decreased ET-1-mediated vasoconstriction is an important mechanism underlying
Introduction
Overweight and obesity are associated with an elevated risk of cardiovascular disease attributable, in part, to endothelial dysfunction (Campia et al. 2012) . We (Van Guilder et al. 2005 Weil et al. 2011 ) and others (Mather et al. 2002) have demonstrated that increased adiposity, independent of other risk factors and co-morbidities, is associated with a myriad of endothelial abnormalities, particularly vasomotor dysfunction. Indeed, forearm blood flow (FBF) responses to a variety of endothelial agonists have been shown to be significantly lower in overweight and obese adults compared with normal weight adults; indicating profound impairment in endothelium-dependent vasodilatation with increased adiposity (Van Guilder et al. 2008) . Moreover, the activity of endothelin-1 (ET-1), the most potent vasoconstrictor peptide produced by the endothelium, is markedly elevated in overweight and obese adults (Weil et al. 2011) . Increased ET-1-mediated vasoconstrictor tone is a key factor not only underlying endothelial vasodilator dysfunction but also involved in the pathogenesis and progression of atherosclerotic vascular disease (Miyauchi & Masaki, 1999; Dashwood & Tsui, 2002) .
Regular aerobic exercise is highly recommended for cardiovascular disease risk reduction in overweight and obese adults, with or without dietary modification or weight loss. Several studies have demonstrated that the prevalence of cardiovascular disease-related morbidity and mortality is significantly lower in habitually physically active overweight and obese adults compared with their sedentary peers of similar age and body fatness (Blair et al. 1989; Blair & Brodney, 1999; Farrell et al. 2002) . An important contributing factor to this reduction in cardiovascular disease risk and burden is thought to be improved endothelial function. Regular aerobic exercise (daily walking), independent of weight loss and changes in diet, has been shown to improve endothelium-dependent vasodilatation in overweight and obese adults (Mestek et al. 2010) . The mechanisms responsible for the exerciseinduced enhancement in endothelial vasodilator function in overweight and obese adults, however, are not well understood. Although habitual aerobic exercise has been shown to have a favourable effect on nitric oxide bioavailability, endothelium-dependent vasodilator dysfunction with overweight and obesity has been shown to be independent of nitric oxide deficiency (Van Guilder et al. 2008) . It is currently unknown whether regular aerobic exercise reduces ET-1-mediated vasoconstrictor tone in overweight and obese adults; and, if so, whether reduced ET-1 vasoconstriction underlies exercise-induced improvement in endothelium-dependent vasodilatation in this population.
Accordingly, the aims of the present study were to determine the followng: (i) whether regular aerobic exercise training reduces ET-1-mediated vasoconstrictor tone in overweight and obese adults; and, if so, (ii) whether the reduction in ET-1-mediated vasoconstriction contributes to exercise-induced improvement in endothelium-dependent vasodilatation in this population. To address these aims, we used an isolated forearm model to determine the FBF responses to selective ET A receptor antagonism separately and in combination with the endothelial agonist acetylcholine before and after an aerobic exercise training intervention. We hypothesized that aerobic exercise training reduces ET-1-mediated vasoconstrictor tone and, in turn, lower ET-1 vasoconstriction contributes mechanistically to exercise-related enhancement in endothelium-dependent vasodilatation in overweight and obese adults.
Methods

Ethical approval
The ethical committee of the University of Colorado Boulder approved the study (approval no. 0304.25). The study conformed to the standards set by the Declaration of Helsinki (apart from registration in a database). Prior to participation, all subjects had the research study and its potential risks and benefits explained fully before providing written informed consent according to the guidelines of the University of Colorado Boulder.
Subjects
Thirty-seven sedentary middle-aged and older adults (age range 41-64 years) were studied: 12 (four men and eight women) normal weight (body mass index range 18.7-25.0 kg m −2 ) and 25 (16 men and nine women) overweight and obese (28.0-36.9 kg m −2 ).
All subjects were normotensive (arterial blood pressure ࣘ140/90 mmHg) and free of overt cardiovascular disease as assessed by medical history, physical examination, fasting blood chemistry, and ECG measured at rest and during incremental exercise performed to exhaustion. None of the subjects smoked, were taking medications (including vitamins or other dietary supplements) or performed regular aerobic physical activity for ࣙ1 year before study participation. All of the women were at least 1 year postmenopausal and had never taken or had discontinued use of hormone replacement therapy ࣙ1 year before the start of the study.
Body composition
Body mass was measured to the nearest 0.1 kg using a medical beam balance (Detecto, Webb City, MO, USA). Body mass index was calculated as the weight in kilograms divided by the height in metres squared. The percentage of body fat was determined by dual energy X-ray absorptiometry (Lunar Corp., Madison, WI, USA). Minimal waist circumference was measured according to published guidelines (Lohman et al. 1988) .
Maximal oxygen consumption
Aerobic fitness was assessed by incremental treadmill exercise using a modified Balke protocol. Maximal oxygen consumption (V O 2 max ) was measured with online computer-assisted open circuit spirometry, as previously described (DeSouza et al. 1998) . Heart rate was measured throughout the protocol, and the rating of perceived exertion and total exercise time to exhaustion were recorded.
Metabolic measurements
Fasting plasma lipid and lipoprotein, glucose and insulin concentrations were determined using standard techniques by the clinical laboratory affiliated with the Clinical Translational Research Center at the University of Colorado Boulder.
Intra-arterial infusion protocol
All measurements were performed in a temperaturecontrolled room between 07.00 and 10.00 h after an overnight fast, as previously described by researchers in our laboratory (Van Guilder et al. 2008) . Briefly, a 5 cm, 20-gauge catheter was inserted into the brachial artery of the non-dominant arm under local anesthesia (1% lidocaine). The FBF was measured via straingauge venous occlusion plethysmography at rest and in response to each pharmacological agent. After the measurement of resting blood flow for 5 min, acetylcholine (IOLAB Pharmaceuticals, Duluth, GA, USA) was infused intra-arterially at rates of 4.0, 8.0 and 16.0 μg (100 ml tissue) −1 min −1 and sodium nitroprusside (Nitropress; Abbott Laboratories, Abbott Park, IL, USA) at 1.0, 2.0 and 4.0 μg (100 ml tissue) −1 min −1 for 5 min at each dose. Flow was recorded four times each minute at rest and throughout each drug infusion protocol. Flows during the last minute of rest and each drug dose were measured and the mean value reported. After the initial infusions of acetylcholine and sodium nitroprusside, BQ-123 (Clinalfa AG, Bubendorf, Switzerland), a selective ET A receptor antagonist, was infused at a rate of 100 nmol min −1 for 60 min, and FBF was measured every 10 min for at least 1 min and the mean value reported. After 60 min, infusion of BQ-123 was continued at the same dose, and FBF was measured during co-administration of acetylcholine as performed earlier. The co-infusion of acetylcholine plus BQ-123 was performed only in the overweight/obese adults.
Exercise intervention
The overweight/obese subjects participated in a 3 month home-based aerobic exercise-training programme that has been previously described by researchers in our laboratory (Van Guilder et al. 2007 ). The normal weight adults did not participate in the exercise intervention. Briefly, subjects were instructed to exercise 5-7 days each week for 45-60 min day −1 at 65-75% of their individual maximal heart rate, as determined during the maximal exercise test. Most subjects walked, but some incorporated jogging as their fitness improved in order to maintain their heart rate within the prescribed range. Compliance with the exercise programme was documented every 2 weeks with data downloaded from heart rate monitors (Polar Electro, Kempele, Finland) and review of exercise logs.
Statistical analysis
Differences in subject baseline physical and metabolic characteristics between the normal weight and overweight/obese groups at baseline were determined by one-way ANOVA. Group differences in the FBF responses to acetylcholine, sodium nitroprusside, BQ-123 and acetylcholine plus BQ-123 were determined by repeated-measures ANOVA. When indicated by a significant F value, a Newman-Keuls post hoc test was performed to identify differences among the groups. Changes in physical and metabolic characteristics as well as FBF responses to acetylcholine, sodium nitroprusside, BQ-123 and acetylcholine plus BQ-123 resulting from the exercise intervention in the overweight/obese adults (the normal weight adults did not participate in the 109 ± 31 123 ± 20 113 ± 27 † Triglycerides (mg dl −1 ) 9 0 ± 39 114 ± 50 90 ± 43 † Glucose (mg dl −1 ) 8 6 ± 12 84 ± 11 86 ± 10 Insulin (μU ml −1 ) 7 . 9 ± 2.6 8.7 ± 3.6 7.8 ± 3.3
Abbreviations: BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; and LDL, low-density lipoprotein. Values are means ± SD. * P < 0.05 versus normal weight; † P < 0.05 versus before exercise.
exercise intervention) were assessed by repeated-measures ANOVA. There were no significant sex interactions; thus, all data were pooled and presented together. Relations between variables of interest were assessed by linear regression analysis. All data are expressed as means ± SEM. Statistical significance was set a priori at P < 0.05.
Results
Selected subject characteristics are presented in Table 1 . Body mass, body mass index and percentage body fat were higher (P < 0.05) in the overweight/obese group compared with the normal weight group. There were no significant group differences in any haemodynamic or metabolic variables.
Cross-sectional study: FBF responses to vasodilator and vasoconstrictor agents in the normal weight and overweight/obese adults
Group differences in FBF responses to acetylcholine and sodium nitroprusside are shown in Fig. 1 . The FBF responses to acetylcholine were significantly blunted (ß20%) in the overweight/obese group [from 4.3 ± 0.2 to 11.0 ± 0.4 ml (100 ml tissue) −1 min −1 ] compared with the normal weight group [from 4.1 ± 0.4 to 13.9 ± 0.7 ml (100 ml tissue) −1 min −1 ]. The vasodilator response to sodium nitroprusside was not significantly different between the groups. The FBF responses to selective ET A receptor blockade with BQ-123 were markedly different (P < 0.05) between groups (Fig. 2) . In normal weight adults, resting FBF was not significantly altered by BQ-123, whereas in the overweight/obese group BQ-123 elicited a significant vasodilator response (ß25%).
Intervention study: effects of aerobic exercise intervention on FBF responses to vasodilator and vasoconstrictor agents in overweight/obese adults
All 25 overweight/obese adults completed the 3 month home-based exercise intervention. The subjects exercised an average of 4.9 ± 0.2 days each week for 51 ± 2 min day −1 at an intensity of 72 ± 1% of maximal heart rate. There were no significant changes in body mass, body mass index, body fat percentage, blood pressure, high-density lipoprotein-cholesterol, glucose or insulin concentrations in response to exercise training (Table 1) . Although total cholesterol, low-density lipoprotein-cholesterol and plasma triglycerides were all well within clinically normal values, their concentrations were lower (P < 0.05) after the exercise intervention. AlthoughV O 2 max was unchanged, aerobic exercise training increased exercise time to exhaustion by ß20% (P < 0.05) and significantly decreased heart rate and rating of perceived exertion at the same absolute submaximal level of exercise (ß70% of baselineV O 2 max ; Table 2 ).
Regular aerobic exercise training significantly reduced ET A receptor-mediated vasoconstrictor tone (Fig. 3) . After the exercise intervention, BQ-123 elicited a small, nonsignificant increase in resting FBF in the previously sedentary overweight/obese adults compared with significant vasodilatation (ß25%) before the exercisetraining programme. Additionally, FBF responses to acetylcholine were markedly higher (ß20%; P < 0.05) after exercise training [from 4.3 ± 0.2 to 13.0 ± 0.6 ml (100 ml tissue) −1 min −1 ] compared with before training [from 4.3 ± 0.2 to 11.0 ± 0.4 ml (100 ml tissue) −1 min −1 ; Fig. 4 ]. The FBF responses to sodium nitroprusside did not change significantly in response to the aerobic exercise intervention (Fig. 4) .
Before aerobic exercise training, the co-infusion of BQ-123 with acetylcholine resulted in an enhanced (ß20%; P < 0.05) vasodilator response [from 4.4 ± 0.3 to 12.6 ± 0.7 ml (100 ml tissue) −1 min −1 ] compared with acetylcholine alone [from 4.3 ± 0.2 to 11.0 ± 0.4 ml (100 ml tissue) −1 min −1 ]. Indeed, total blood flow response to acetylcholine (area under the curve) was ß45% greater [64.6 ± 4.9 versus 46.4 ± 2.7 ml (100 ml tissue) acetylcholine (Fig. 5) . There was no significant difference in the FBF responses to acetylcholine in the presence [from 4.4 ± 0.2 to 13.4 ± 0.6 ml (100 ml tissue) −1 min −1 ] or absence of BQ-123 [from 4.3 ± 0.2 to 13.0 ± 0.6 ml (100 ml tissue) −1 min −1 ]. Moreover, there was no significant difference in the total blood flow response to acetylcholine with and without BQ-123 [66.9 ± 4.3 versus 63.6 ± 4.7 ml (100 ml tissue)
−1 ] after the exercise intervention.
The modest, albeit significant, changes in plasma total cholesterol, low-density lipoprotein-cholesterol or triglycerides with the exercise intervention were not significantly correlated with the peak changes in FBF to either BQ-123 (r = −0.25, r = −0.13 and r = −0.34, respectively) or acetylcholine (r = 0.17, r = 0.14 and r = −0.14, respectively). 
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Discussion
The primary new finding of the present study is that habitual moderate-intensity aerobic exercise training reduces ET-1-mediated vasoconstrictor tone in overweight/obese adults. Moreover, the exercise-induced improvement in endothelium-dependent vasodilatation observed in overweight/obese adults is predominantly attributable to diminished ET-1 vasoconstriction. To the best of our knowledge, this is the first study to determine the following factors: (i) the effects of aerobic exercise training on ET-1-mediated vasoconstrictor tone in overweight/obese adults; and, in turn, (ii) the mechanistic influence of the ET-1 system in mediating favourable changes in endothelial vasodilator function with regular aerobic exercise in this population.
Consistent with previous studies involving similar study populations and measurement techniques, we demonstrate that endothelial vasomotor function is impaired in overweight/obese adults. Specifically, overweight/obesity, independent of other cardiometabolic risk factors and/or disease, is associated with reduced endothelium-dependent vasodilatation and enhanced ET-1-mediated vasoconstrictor tone (Van Guilder et al. 2008; Weil et al. 2011) . The results of the present study significantly extend our understanding of endovascular function in overweight/obese adults by providing new insight regarding the important vasculoprotective effects of regular aerobic exercise in this population. It is well established that habitual physical activity that is aerobic in nature is an effective lifestyle strategy for improving endothelial vasodilator function in overweight and obese adults (De Filippis et al. 2006; Schjerve et al. 2008; Mestek et al. 2010; Swift et al. 2012) . For example, 6 months of aerobic exercise training has been shown to improve flow-mediated dilatation in previously sedentary obese postmenopausal women (Swift et al. 2012) . Moreover, Mestek et al. (2010) , studying a similar population of overweight/obese adults to those herein and using the same 3 month home-based moderate aerobic exercise intervention, demonstrated significant increases in acetylcholine-stimulated endothelium-dependent vasodilatation in response to exercise training. In fact, the magnitude of improvement in FBF response to acetylcholine (ß35%) after the exercise intervention reported by Mestek et al. (2010) is similar to that observed in the present study. Importantly, the endovascular effects of habitual aerobic exercise extend beyond endothelium-dependent vasodilatation. Indeed, a seminal finding of the present study is that moderate aerobic exercise training (daily walking) reduces ET-1-mediated vasoconstriction in overweight/obese adults. Before the exercise intervention, ET A receptor blockade elicited a significant increase in resting FBF in the overweight/obese adults, indicative of enhanced ET A receptor-mediated ET-1 vascontrictor tone. After the exercise intervention, the vascular response to ET A blockade was markedly diminished and comparable to that of the normal weight subjects, suggesting that regular aerobic exercise can counteract the elevation in ET-1-mediated vasoconstriction associated with overweight and obesity.
The mechanisms underlying the exercise-induced reduction in ET A receptor-mediated ET-1 vasocontrictor tone in the overweight/obese adults is not clear. Oxidative stress and inflammation are independently associated with both adiposity and heightened ET-1 system activity (Festa et al. 2001; Keaney et al. 2003) . It is possible that favourable changes in oxidative and inflammatory stress (such as superoxide anion, C-reactive protein and tumour necrosis factor-α, factors linked with ET-1 production; Patel et al. 2002; Verma et al. 2002; Pollock & Pollock, 2005) that can result from habitual aerobic exercise (Farinha et al. 2015; Sallam & Laher, 2016 ) might contribute to the diminution in ET-1-mediated vasoconstriction. Unfortunately, these and other markers of systemic oxidative stress and inflammation were not measured in the present study. Although the exercise intervention resulted in modest, albeit significant, reductions in 
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total cholesterol, low-density lipoprotein-cholesterol and tryglycerides, the changes in these variables were not associated with the vascular responses to BQ-123. Moreover, the exercise-induced reduction in ET-1-mediated vasoconstriction was independent of changes in adiposity. Sympathetic nervous system activity is exaggerated with adiposity (Alvarez et al. 2002; Davy & Orr, 2009 ) and has been linked with increased ET-1 (Schiffrin, 2005) . Regular aerobic exercise is thought to influence sympathetic activity (Meredith et al. 1991; Cornelissen & Fagard, 2005) ; therefore, it is plausible that reductions in sympathetic activity might play a role in lowered ET-1-mediated vasoconstriction. The role of nitric oxide in exercise-induced ET-1 suppression is not clear. Nitric oxide is the most potent vasodilator produced by the endothelium and also serves as a mediator of ET-1 production by modulating transcription of the pre-pro-ET-1 mRNA (Le Brocq et al. 2008) . Regular aerobic exercise is a known stimulus for nitric oxide production (Phillips et al. 2015) ; it is possible that increased nitric oxide bioavailability abated ET-1 production.
Regardless of the mechanisms involved, the reduction in ET-1 vasoconstrictor tone with aerobic exercise training provides new insight into the beneficial effects of regular aerobic exercise on endothelium-dependent vasodilatation. We have previously demonstrated that the impairment in acetylcholine-stimulated endotheliumdependent vasodilatation with overweight and obesity is directly linked to enhanced ET A receptor-mediated ET-1 vasoconstriction (Weil et al. 2011) . The results of the present study complement and extend these previous findings by demonstrating that the exercise-induced improvement in endothelium-dependent vasodilatation is a result of reduced ET A receptor-mediated vasoconstriction. Before the exercise intervention, the co-infusion of the selective ET A receptor blocker, BQ-123, significantly increased the vasodilator response to acetylcholine compared with acetylcholine alone, providing further evidence that diminished endothelium-dependent vasodilatation with overweight/obesity is attributable to enhanced ET-1-mediated vasoconstrictor tone. However, after 3 months of moderate aerobic exercise training BQ-123 no longer enhanced the FBF responses to acetylcholine, indicating that the exercise-induced improvement in endothelium-dependent vasodilatation in overweight/obese is attributable to diminished ET A receptor-facilitated ET-1-mediated vasoconstriction. It is plausible that elimination of ET-1-mediated vasoconstriction allowed nitric oxide and other endothelium-derived relaxing factors to act unopposed and dilate the vessel appropriately in response to acetylcholine. Reducing ET-1-mediated vasoconstrictor tone is not only an important endovascular adaptation favourably affecting vasomotor regulation but also a potential mechanism contributing to the well-established cardioprotective effects of regular aerobic exercise (Myers, 2003) . Indeed, ET-1 activity contributes to the pathogenesis and development of atherosclerosis (Kelly & Whitworth, 1999; Miyauchi & Masaki, 1999) , and ET-1-mediated vasoconstrictor tone is elevated in a myriad of co-morbidities associated with adiposity, such as hypertension (Cardillo et al. 1999) , type 2 diabetes (Cardillo et al. 2002) and dyslipidaemia (Cardillo et al. 2000) .
From a clinical and public health perspective, it is important to emphasize that the vasomotor adaptations observed in the overweight/obese adults in response to habitual aerobic exercise training were independent of weight loss and resulted from a home-based, moderate aerobic exercise training programme (daily walking) that most, if not all, overweight and obese adults can perform, regardless of age. Moreover, the prevalence of cardiovascular-related morbidity and mortality is significantly lower in overweight and obese adults who are habitually physically active (Lee et al. 1999; Farrell et al. 2002; Katzmarzyk et al. 2004) . Thus, although weight loss is often the main focal point of lifestyle interventions with overweight/obese adults, the results of this and other studies (Van Guilder et al. 2005; Mestek et al. 2010) demonstrate that many important vascular benefits of regular aerobic exercise can be achieved without a change in body mass or composition in this at risk population.
There are a few experimental considerations of the present study that deserve mention. Firstly, the absence of a non-exercise control group precludes us from completely ruling out the possibility that the results of the study were attributable to chance, experimental bias or both. However, the 3 month home-based aerobic exercise training programme used in the present study has been repeatedly shown to improve endothelial function, independent of changes in body mass and/or cardiometabolic risk factors, in adult humans varying in age and body composition (DeSouza et al. 2000; Van Guilder et al. 2005 , 2007 Mestek et al. 2010) . Thus, we are confident that the exercise-induced changes in both endothelial vasodilatation and vasoconstriction as well as the interaction between the two vasomotor functions were indeed a primary effect of the exercise intervention. Secondly, we recognize that the study design would have been more robust with the inclusion of nitric oxide inhibition. Experimentally, this would have been advantageous by providing the ability to pharmaco-dissect the possible contributing role of nitric oxide in the exercise-induced reduction in ET-1-mediated vasoconstrictor tone and the concomitant enhancement in endothelial vasodilator capacity. However, the prolonged half-life of the vasoactive agents, especially BQ-123, would have significantly extended the experimental session and would have been too burdensome for the subjects. Thirdly, we have previously demonstrated that the vasoconstrictor response to exogenous ET-1 is lower in overweight and obese adults, suggesting that ET-1 bioavailability is elevated with increased adiposity (Weil et al. 2011) . In the present study, however, we were unable to repeat these studies and precisely determine the effects of habitual aerobic exercise on ET-1 production owing to a lack of availability of pharmaceutical grade ET-1 for human use. However, we have previously demonstrated in older adults that regular aerobic exercise (same home-based aerobic exercise intervention described herein) does reduce ET-1 bioavailability in vivo in conjunction with diminished ET A receptor-mediated vasoconstrictor tone (Van Guilder et al. 2007) . Thus, it is not unreasonable to postulate that the exercise-induced reduction in ET-1-mediated vasoconstrictor tone observed in the overweight/obese adults in the present was atributable, at least in part, to diminished ET-1 production.
In conclusion, the results of this study demonstrate that regular aerobic exercise reduces ET-1-mediated vasoconstrictor tone in previously sedentary overweight and obese adults, independent of weight loss. Moreover, decreased ET-1 vasoconstriction is an important mechanism underlying the aerobic exercise-induced improvement in endothelium-dependent vasodilator function in overweight/obese adults. Reduced ET-1-mediated vasoconstrictor tone may represent an important cardioprotective mechanism contributing to the lower prevalence of cardiovascular morbidity and mortality in overweight/obese adults who engage in habitual aerobic exercise.
